63
Views
13
CrossRef citations to date
0
Altmetric
Miscellaneous

Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma

, , , , , & show all
Pages 445-448 | Received 31 Jan 2005, Published online: 07 Jul 2009

References

  • Zhang JY, Casiano CA, Peng XX, et al. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomark Prev 2003; 12: 136–143
  • Masumoto K, Kaneko S, Yasukawa M, et al. Identification of serum anti-human telomerase reverse transcriptase (hTERT) auto-antibodies during progression to hepatocellular carcinoma. Oncogene 2002; 21: 5946–5950
  • Yagihashi A, Asanuma K, Nakamura M, et al. Detection of anti-survivin antibody in gastrointestinal cancer patients. Clin Chem 2001; 47: 1729–1731
  • Koziol JA, Zhang JY, Casiano CA, et al. Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. Clin Cancer Res, 2003;9:–5126.
  • Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917–921
  • Altieri DC. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003; 22: 8581–8589
  • Li F. Survivin study: What is next wave?. J Cell Physiol 2003; 197: 8–29
  • Ashhab Y, Alian A, Plliack A, et al. Two splicing variants of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett 2001; 495: 56–60
  • Bain I, McMaster P. Benign and malignant liver tumors. Surgery 1997; 15: 169–174
  • Fong Y, Sun RL, Jarnagin W, et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229: 790–800
  • Ikeguchi M, Ueda T, Sakatani T, et al. Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. Diagn Mol Pathol 2003; 11: 33–40
  • Ikeguchi M, Hirooka Y, Kaibara N. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Cancer 2003; 95: 1938–1945
  • Raedle J, Oremek G, Truschnowitsch M, et al. Clinical evaluation of antibodies to p53 protein in patients with chronic liver disease and hepatocellular carcinoma. Eur J Cancer 1998; 34: 1198–1203
  • Waris G, Siddiqui A. Regulatory mechanism of viral hepatitis B and C. J Biosci 2003; 28: 311–321
  • Kountouras J, Zavos C, Chatzopoulos D. Apoptosis in hepatitis C. J Viral Hepatitis 2003; 10: 335–342
  • Shmitz M, Diestelkoetter P, Weigle B, et al. Generation of survivin-specific CD8+T effector cells by dendritic cells pulsed with protein or selected peptides. Cancer Res 2000; 60: 4845–4849
  • Reker S, Meier A, Holten-Anderson L, et al. Identification of novel survivin-derived CTL epitopes. Cancer Biol Ther 2004; 3: 173–179
  • Hirohashi Y, Torigoe T, Maeda A, et al. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. Clin Cancer Res 2002; 8: 1731–1739
  • Reker S, Becker JC, Svane IM, et al. HLA-B35-restricted immune responses against survivin in cancer patients. Int J Cancer 2004; 108: 937–941

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.